Total medical devices industry M&A deals worth $831.84m were announced in North America in February 2021, led by Veracyte’s $600m acquisition of Decipher Biosciences, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 96.2% over the previous month of $22.04bn and a drop of 88% when compared with the last 12-month average of $6.93bn.
North America held a 96.52% share of the global medical devices industry M&A deal value that totalled $861.84m in February 2021. With a 96.52% share and deals worth $831.84m, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 31 deals during February 2021, marking a decrease of 6.06% over the previous month and a rise of 40.91% over the 12-month average. The US recorded 28 deals during the month.
North America medical devices industry M&A deals in February 2021: Top deals
The top five medical devices industry M&A deals accounted for 99.6% of the overall value during February 2021.
The combined value of the top five medical devices deals stood at $828.34m, against the overall value of $831.84m recorded for the month.
The top five medical devices industry M&A deals of February 2021 tracked by GlobalData were:
1) Veracyte’s $600m acquisition of Decipher Biosciences
2) The $150m acquisition of Simplify Medical by NuVasive
3) Mind Medicine MindMed’s $32.66m acquisition of HealthMode
4) The $23.68m acquisition of Chronix Biomedical by OncoCyte
5) Volpara Solutions’ acquisition of CRA Health for $22m.